Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer

NCT01614938 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Cetuximab
DRUG: Cisplatin
DRUG: Docetaxel
RADIATION: Intensity-modulated radiotherapy
DRUG: Cisplatin

Sponsor

Fudan University